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Abstract
Several types of psychological treatment for posttraumatic stress disorder (PTSD) are consid-
ered well established and effective, but evidence of their long-term efficacy is limited. This sys-
tematic review and meta-analysis aimed to investigate the long-term outcomes across
psychological treatments for PTSD. MEDLINE, Cochrane Library, PTSDpubs, PsycINFO,
PSYNDEX, and related articles were searched for randomized controlled trials with at least
12 months of follow-up. Twenty-two studies (N = 2638) met inclusion criteria, and 43 com-
parisons of cognitive behavioral therapy (CBT) were available at follow-up. Active treatments
for PTSD yielded large effect sizes from pretest to follow-up and a small controlled effect size
compared with non-directive control groups at follow-up. Trauma-focused treatment (TFT)
and non-TFT showed large improvements from pretest to follow-up, and effect sizes did
not significantly differ from each other. Active treatments for comorbid depressive symptoms
revealed small to medium effect sizes at follow-up, and improved PTSD and depressive symp-
toms remained stable from treatment end to follow-up. Military personnel, low proportion of
female patients, and self-rated PTSD measures were associated with decreased effect sizes for
PTSD at follow-up. The findings suggest that CBT for PTSD is efficacious in the long term.
Future studies are needed to determine the lasting efficacy of other psychological treatments
and to confirm benefits beyond 12-month follow-up.
Introduction
Posttraumatic stress disorder (PTSD) is a highly prevalent and chronic mental disorder
(Kessler et al., 2017), associated with personal (Schnurr, Lunney, Bovin, & Marx, 2009) and
societal costs (McGowan, 2019). Half (52%) of individuals with PTSD suffer from
co-occurring depression (Rytwinski, Scur, Feeny, & Youngstrom, 2013); a comorbidity asso-
ciated with severe symptoms, reduced functioning, and poorer treatment response in PTSD
(Bedard-Gilligan et al., 2015; Haagen, Heide, Mooren, Knipscheer, & Kleber, 2017). Given
its chronic course and high personal and economic burden, it is crucial to identify effective
psychological treatments for PTSD both in the immediate and long-term phase.
Numerous psychological PTSD treatments have been developed which can be differentiated
by content (e.g. Ehlers et al., 2010). Trauma-focused treatment (TFT) mainly focusses on pro-
cessing the individual’s memory of the trauma and/or its meaning. Trauma-focused cognitive
behavioral therapy (TF-CBT) typically incorporate psychoeducation, homework, relaxation,
and cognitive and/or behavioral-based components (e.g. cognitive therapy, Ehlers & Clark,
2000; cognitive processing therapy, Resick & Schnicke, 1992; prolonged exposure, Foa &
Rothbaum, 1998; Foa, Hembree, & Rothbaum, 2007; narrative exposure therapy, Schauer,
Neuner, & Elbert, 2011). Eye Movement Desensitization and Reprocessing (Shapiro, 1995)
recalls the traumatic memory using bilateral movements and some core elements of
TF-CBT. Non-TFTs typically address coping with symptoms, emotion regulation, or current
problems in life without a primary focus on the trauma. Techniques of non-TF-CBT comprise,
inter alia, anxiety management, relaxation, stress management, social skills training, positive
thinking, assertiveness training, or thought stopping (International Society for Traumatic
Stress Studies, 2015; e.g. stress inoculation training, Veronen & Kilpatrick, 1983; seeking safety,
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Najavits, 2002). Series of other PTSD treatments exist (e.g. psy-
chodynamic therapies or hypnotherapy), but are less frequently
studied (Cusack et al., 2016).
Several systematic reviews and meta-analyses demonstrate the
efficacy of psychological treatment for PTSD (e.g. Benish, Imel, &
Wampold, 2008; Chen, Zhang, Hu, & Liang, 2015; Cusack et al.,
2016; Gerger et al. 2014; Haagen, Smid, Knipscheer, & Kleber,
2015; Lambert & Alhassoon, 2015; Lenz, Haktanir, & Callender,
2017; Sloan, Gallagher, Feinstein, Gayle Beck, & Keane, 2013;
Thompson, Vidgen, & Roberts, 2018; Watts et al., 2013).
TF-CBT has the strongest empirical support and current practice
guidelines recommend this type of psychological treatment as
first-line therapy for PTSD (e.g. American Psychological
Association, [APA], 2017; Schäfer et al., 2019). Current evidence
for TF-CBT and psychological treatment for PTSD in general,
however, mainly relies on short-term outcomes; meta-analyses
investigating its long-term benefits (e.g. 12 months after treat-
ment) are largely missing. Understanding the long-term out-
comes of psychological treatment for PTSD and identifying
moderators of sustainable gains is critical for both clinical practi-
tioners and researchers, particularly to inform clinical decision-
making and to stimulate research into effective psychological
treatment (e.g. in specific patient groups).
Seven recent systematic reviews and meta-analyses examined
the lasting benefits of psychological treatment in adult PTSD.
Their findings mainly represent treatment effects at short-term
to medium-term, indicating medium to large improvements in
PTSD symptoms up to 6 months of follow-up (Bisson, Roberts,
Andrew, Cooper, & Lewis, 2013; Carpenter et al., 2018; Ehring
et al., 2014; Kline, Cooper, Rytwinksi, & Feeny, 2018; Lee et al.,
2016; Mavranezouli et al., 2020; van Dis et al., 2020). Two of
these studies give insights into the long-term treatment effects
of PTSD, i.e. at 12-month follow-up and above. One
meta-analysis investigated evidence-based treatments for PTSD
at medium-term, with at least 6 months of follow-up (Kline
et al., 2018). The findings were based on uncontrolled comparison
only, and showed larger treatment effects for active treatments
from baseline to medium-term follow-up (d = 2.14) compared
to active control conditions for the same period (d = 1.04).
Uncontrolled comparisons between psychological treatments for
PTSD demonstrated no significant differences from pretest to
follow-up. For the posttest to follow-up phase, exposure-based
treatments were superior, while CBTs without exposure were
inferior to all other treatments combined. Of the 32 included
trials, eight studies (25%) had a 12-month follow-up. Only one
study comprised more than 12 months of follow-up, making it
difficult to disentangle any long-term benefit from medium-term
outcomes. Another meta-analysis focused on CBT for anxiety dis-
orders compared with usual care or wait-list group with at least 1
month of follow-up (van Dis et al., 2020). Longer-term outcomes
for PTSD alone showed medium effects at 6–12 month of
follow-up and large treatment effects compared with the control
group at more than 12 months of follow-up. The analyses were
limited to direct comparisons, and 16 studies with a follow-up
of at least 6 months were available for PTSD.
This systematic review and meta-analysis aimed to investigate
the long-term outcomes across psychological treatments for adults
with PTSD. We aimed to assess PTSD severity and comorbid
depressive symptoms at least 12 months after treatment comple-
tion. Using comparisons both within and between studies, we
aimed to increase the number of available studies with a long-
term follow-up but simultaneously control for time and placebo
effects. We examined whether (1) psychological treatment dif-
fered from control groups and whether (2) TFT differed from
non-TFT in PTSD severity and comorbid depressive symptoms
at long-term follow-up. In addition, we investigated specific mod-
erators and their potential impact on long-term benefits of psy-
chological treatment for PTSD.
Method
We followed the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) statement for conducting and
reporting this meta-analysis (Liberati et al., 2009, see Appendix
A). The study protocol was not registered a priori.
Eligibility criteria
Studies were selected if they comprised (1) face-to-face psycho-
logical treatment for PTSD, (2) adult participants, (3) at least
70% of participants diagnosed with PTSD (e.g. according to
DSM-IV/V, ICD-10); (4) either active or passive, nonpharmacolo-
gical control conditions (e.g. supportive counseling, wait-list) or
psychological treatment as comparators; (5) PTSD severity as pri-
mary outcome measured at least 12 months after the end of treat-
ment; (6) a randomized controlled trial design, and (7) at least ten
participants per treatment arm. Trials were included based on any
type of trauma, type of setting (e.g. inpatients, outpatients), pres-
ence of comorbidity, or adjuvant drug treatment (e.g. by prescrip-
tion or as part of the study protocol).
Selection of studies
A systematic literature search in MEDLINE, PsycINFO,
PSYNDEX, PTSDpubs, and Cochrane Library was conducted
for articles in English or German language until November 7,
2019. The search strategy derived from the preparation of the
German S3 treatment guideline for PTSD (Schäfer et al., 2019),
and included the following keywords: (PTSD OR OR
Posttraumatische Belastungsstörungen or PTBS) AND ((treat-
ment trial OR randomized controlled trial) or (indexed by a the-
saurus term as a clinical trial)). In addition, we performed a
systematic snowball search by screening reference lists from
included primary studies and relevant review articles. Two
researchers independently screened articles and decided on eli-
gible studies. In cases of disagreement between the researchers,
a third researcher decided on eligibility.
Data extraction
Several study characteristics were extracted (see Appendix A).
Means and standard deviations or reported effect sizes for
PTSD severity (primary outcome) and comorbid depressive
symptoms (secondary outcome) were extracted at baseline, postt-
est, and at ⩾12 months after treatment completion. In cases of
multiple follow-up intervals, data from the latest was used (e.g.
Karyotaki et al., 2016; Kline et al., 2018). Data for clinician-rated
PTSD and intent-to-treat samples (ITT) were extracted if avail-
able. If further statistical data or data subsets were needed (e.g.
for adult subsample), we contacted the study authors and sent a
follow-up e-mail in case of non-response (57% response rate).
One researcher (MW) extracted data, which were cross-checked
by a second (SSch) to ensure accuracy.
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Treatment coding
We coded treatment conditions as psychological treatment or
control. Psychological treatment was classified as TFT or
non-TFT (Ehring et al., 2014; see Ehlers et al., 2010 for discus-
sion). Control conditions were rated as active, if interventions
were not directive or trauma-focused such as supportive counsel-
ing or treatment as usual (TAU), and served to control for
non-specific mechanisms (e.g. Kline et al., 2018; Lambert &
Alhassoon, 2015; Powers, Halpern, Ferenschak, Gillihan, & Foa,
2010). We classified control groups as passive if there was no clin-
ician involvement, i.e. during wait-list. Treatment coding was
performed by two independent researchers (MW, WH), and a
third (BK) was consulted if raters disagreed.
Study quality assessment
The included studies were assessed using the six domains from
the Cochrane risk of bias tool (Higgins et al., 2011): (1) random
sequence generation, (2) allocation concealment, (3) blinding of
participants, personnel, and (4) outcome assessment, (5) incom-
plete outcome data (e.g. if no ITT data were available for
follow-up analysis), and (6) selective outcome reporting (e.g. if
studies deviated from trial registration). All domains were rated
as either low, unclear (unknown), or high risk of bias closely fol-
lowing the recommendations for risk of bias ratings in psycho-
therapy research (see Munder, & Barth, 2018). Two researchers
independently (MW, WH) coded risk of biases and consulted a
third (SSch) in case of disagreement.
Statistical analyses
Effect size calculation
Two types of effect sizes were estimated using Hedges’ g (Hedges,
1981). Within-group effect sizes were obtained by subtracting the
follow-up (or posttest) mean from the baseline (or posttest) mean.
For between-group effect sizes, the control group mean was sub-
tracted from the treatment group at follow-up or posttest divided
by the pooled standard deviation. For within-group effect sizes, the
standard deviation within groups was used including the correl-
ation between the two measurements (Borenstein, Hedges,
Higgins, & Rothstein, 2009). Both types of effect sizes used were
corrected for small sample biases (Hedges & Olkin, 1985). A mag-
nitude of 0.2, 0.5, and 0.8 represents a small, medium, and large
effect size, respectively (Cohen, 1977). Positive effect sizes indicate
improved symptoms, while the width of the respective 95% confi-
dence interval (CI) quantifies its precision (Borenstein et al., 2009).
Comprehensive meta-analysis software, version 3 (Biostat) was
applied to pool effect sizes using a random-effects model. If no
correlation was available to calculate within-group effect sizes,
sensitivity analyses were performed by replacing the coefficient
with r = 0.2, r = 0.5 and r = 0.8; the default value was set to r = 0.5
(k = 10; Borenstein et al., 2009). Heterogeneity of effect sizes was
tested with the Q-statistic, the I2 value, and by visual inspections of
forest plots. A p-value of the Q-statistic below 0.05 indicates hetero-
geneity (Cochran, 1954). I2 values range from 0 to 100% and suggest
presenceof low (25%),medium (50%), and large (75%)heterogeneity
(Higgins & Thompson, 2002).
Subgroup analysis
Subgroup analyses of treatment conditions (active treatment v. con-
trol condition), treatment types (TFT v. non-TFT) were performed
for the primary and secondary outcome. Dropout rates (i.e. ratio of
participants initiating but not completing treatment; Ehring et al.,
2014) were calculated for both conditions and treatment subgroups.
For PTSD severity, six additional variableswere analyzed: proportion
of female participants [high (⩾50%) v. low (<50%); Sloan et al., 2013;
Watts et al., 2013], type of population (military personnel v. civilian;
Kline et al., 2018), treatment format (individual v. group-based;
Ehring et al., 2014; Haagen et al., 2015), average number of treatment
sessions [high (⩾10 sessions) v. low (<10 sessions); Lambert &
Alhassoon, 2015], outcome measure (self-rated v. clinician-assessed,
Lambert&Alhassoon, 2015), and type of analysis at follow-up (Kline
et al., 2018). Analyses on within-group effect sizes were conducted
using the mixed-effect model and the Q-statistics (Borenstein et al.,
2009) if at least three comparisons per subgroup were available.
Publication bias
We applied Egger’s regression test (Egger, Davey Smith,
Schneider, & Minder, 1997) and Duval and Tweedie’s trim-and-
fill procedure (Duval & Tweedie, 2000) to test publication bias
if data sets contained at least six studies presenting no substantial
heterogeneity (Ioannidis & Trikalinos, 2007; Rothstein, Sutton, &
Borenstein, 2005; Sterne, Becker, & Egger, 2006; Terrin, Schmid,
Lau, & Olkin, 2003).
Results
Included studies
The search yielded 12 286 hits. Twenty-two eligible studies were
included in this meta-analysis (Fig. 1). Studies were published
between 1999 and 2018 and comprised 28–353 participants per
Fig. 1. Long-term outcomes of psychological treatment for PTSD.
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study sample (N = 2638; Median = 101; Table 1). Participants
(53% female) were on average 40 years old and met DSM-III/
IV diagnostic criteria for PTSD (96%). Studies assessed civilian
(64%) and military populations (32%) in individual-based treat-
ment (86%). Nine studies (41%) quantified that 31–100% of par-
ticipants received additional psychotropic medication during
treatment. Five studies (23%) reported a stable medication dose
for > 30 days at study entry for inclusion, and two studies (9%)
excluded participants receiving any additional medication.
Of 46 included treatment conditions at posttest, 35 were active
treatments including 28 TFT (k = 27 TF-CBT, k = 1 EMDR), and
7 non-TFT (all CBT). The 11 active, non-directive control condi-
tions consisted of TAU (k = 5), social counseling (k = 3), present-
centered therapy (k = 2), and educational groups (k = 1). One of
six wait-list conditions was available at follow-up, and thus all
passive control conditions were removed from analyses. Three
active treatment conditions had inadequate follow-up data (k = 2
TF-CBT, k = 1 EMDR), and remained for qualitative and pre-post
analyses, resulting in 43 CBT-based conditions for primary ana-
lyses. The average follow-up lasted 18 months and ranged from
12 to 74 months. Five studies (23%) had more than 12 months of
follow-up. The dropout rate in active treatments (24%, k = 30)
did not significantly differ from active control groups (18%, k = 7,
p = 0.32). Dropouts in TFT (25%, k = 24) did also not differ signifi-
cantly from non-TFT (21%, k = 6, p = 0.42).
Long-term treatment effects on PTSD severity
Within-group effect sizes
Across all active treatments, the pooled within-group effect size
was large for PTSD severity from pretest to follow-up, g = 1.36,
95% CI (1.14–1.57), p < 0.001 (Table 2; see Appendix A for all for-
est plots). Non-directive control conditions showed a medium
effect size for the same period, g = 0.59, 95% CI (0.14–1.04),
p < 0.05. Active treatments were more effective in reducing
PTSD severity compared to non-directive control conditions
from pretest to follow-up, respectively ( p < 0.01). In addition,
TFT and non-TFT types both yielded large within-group
effect sizes from pretest to follow-up g = 1.44, 95% CI (1.20–1.67),
p < 0.001; g = 1.08, 95% CI (0.52–1.63), p < 0.001, and effect sizes
did not significantly differ from each other ( p = 0.24). Fromposttest
to follow-up, PTSD symptoms slightly improved in the active treat-
ment and control conditions, g = 0.33 95%CI (0.23–0.44), p < 0.001;
g = 0.16, 95% CI (0.04–0.28), p < 0.05 (see Appendix A). From
pretest to posttest,within-effect sizeswere large for active treatments
and medium for control groups, g = 1.01, 95% CI (0.87–1.14),
p < 0.001; g = 0.52, 95% CI (0.16–0.87), p < 0.01.
Heterogeneity was large for within-group effect sizes from pre-
test to follow-up across condition and treatment types (Q > 62,
p < 0.001, I2 > 81, Table 2). None of the moderators examined for
PTSD severity – except for self-rated PTSD measure (Q = 5.16,
p = 0.16, I2 = 41.91) – increased homogeneity in active treatments.
However, subgroup analyses showed higher effect sizes for civilian
compared to military populations ( p < 0.01), for studies with larger
proportions of female participants ( p < 0.001), and for interview-
based compared to self-rated outcome measures ( p < 0.001).
Subgroups did not significantly differ regarding treatment format,
number of sessions, type of analysis used, or follow-up duration.
Between-group effect sizes
The pooled between-group effect size comparing active treat-
ments to non-directive control groups was small for improved
PTSD severity at follow-up, g = 0.42, 95% CI (0.15–0.68), p <
0.001 (Table 3). TFT showed a medium controlled effect size
compared with control groups at follow-up, g = 0.51, 95% CI
(0.15-0.86), p < 0.05. The effect size comparing TFT with non-
TFT at follow-up was small and did not reach statistical significance,
g = 0.35, 95%CI (−0.03 to 0.74), p = 0.07. At posttest, between-group
effect sizeswere small favoring active treatmentsandTFTovercontrol
groups, g = 0.24, 95%CI (0.04–0.44),p < 0.05; g = 0.25, 95%CI (0.03–
0.47), p < 0.05 (see Appendix A).
Heterogeneity was moderate for between-condition effect sizes
at follow-up (Q > 26, p < 0.001, I2 > 71), and low in the treatment
type comparison (Q = 0.47, p = 0.79; I2 = 0, k = 3).
Long-term treatment effects on comorbid depressive
symptoms
Within-group effect sizes
Active treatments demonstrated a medium within-group effect
size for reduced depressive symptoms from pretest to follow-up,
g = 0.73, 95% CI (0.55–0.71), p < 0.001 (Table 4). Non-directive
control conditions showed a small effect size from pretest to
follow-up, g = 0.34, 95% CI (0.11–0.58), p < 0.01, which was sig-
nificantly lower compared to the effect size of active treatments
for the same period ( p < 0.05). Within-group effect sizes were
medium for TFTs, g = 0.78, 95% CI (0.58–0.99), p < 0.01, and
small for non-TFTs from pretest to follow-up, g = 0.45, 95% CI
(0.17–0.74), p < 0.01. However, this contrast was statistically not
significant ( p = 0.06). From posttest to follow-up, depressive
symptoms remained stable in active treatments and control con-
ditions, g = 0.10, 95% CI (−0.01 to 0.21), p = 0.08; g = 0.24, 95%
CI (0.09–0.38), p < 0.001 (see Appendix A). Effect sizes from pre-
test to posttest were medium for active treatments and small for
control groups, g = 0.68, 95% CI (0.55–0.80), p < 0.001; g = 0.24,
95% CI (0.09–0.39), p < 0.01.
All within-group effect sizes were largely heterogeneous at
follow-up (Q > 33, p < 0.001; I2 > 76, see Table 3), except for
non-TFTs (Q = 4.54, p = 0.21; I2 = 33.91, k = 4).
Between-group effect sizes
Table 3 reports small and non-significant between-group effect
sizes of active treatments compared with active control conditions
for comorbid depressive symptoms at follow-up, g = 0.15, 95% CI
(−0.02 to 0.31), p = 0.08. Effect sizes of TFT were small compared
with active control groups, g = 0.14, 95% CI (−0.03 to 0.32), p <
0.05, and did not differ statistically significant from non-TFT at
follow-up, g = 0.10, 95% CI (−0.38 to 0.58), p = 0.68. At posttest,
again between-group effect sizes for active treatments and TFTs
were small compared with control groups, g = 0.30, 95% CI
(0.06–0.53), p < 0.05; g = 0.32, 95% CI (0.04–0.59), p = 0.12 (see
Appendix A).
Heterogeneity of between-condition effect sizes was low (Q< 4,
p > 0.05; I2 < 27) to large (Q > 30, p < 0.001; I2 > 80, see Table 3).
Study quality
The overall risk of bias from studies included in this systematic
review and meta-analysis ranged from low (50%) and unclear
(24%) to high (26%) across all bias domains (see Appendix A
for details per study). Most studies generated a low risk of bias
concerning sequence generation (68%, k = 15), allocation conceal-
ment (50%, k = 11), and blinding of outcome assessors (90%, k =
20). Nine studies (41%) provided complete outcome data at
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follow-up indicating a low risk of bias. Nine studies (41%) also
registered or published their study protocol a priori and adhered
to it, while in half of the studies (50%) selective outcome report-
ing remained unclear. Few studies applied blinding of participants
and personnel (9%, k = 2), and only one study had a low risk of
bias in all domains.
Additional analyses
The replaced correlations using r = 0.2 and r = 0.8 revealed mar-
ginally altered within-group effect sizes for active treatments
and control conditions in all comparisons (see Appendix A for
sensitivity analyses).
Publication bias remained untested due to moderate or large
heterogeneity between effect sizes and small number of studies
in our datasets (Ioannidis & Trikalinos, 2007; Rothstein et al.,
2005; Sterne et al., 2006; Terrin et al., 2003).
Discussion
Summary of evidence
This systematic review and meta-analysis of 22 randomized
controlled trials indicate that psychological treatment for adults
with PTSD is efficacious in the long term. Active treatments
yielded large symptom reductions of PTSD from pretest up to
at least 12 months after initial treatment. Small treatment effects
favored psychological treatment over non-directive control groups
at follow-up, and symptom improvements remained stable from
posttest to follow-up. TFT and non-TFT yielded large sustained
improvements in PTSD frompretest to follow-up. Treatment effects
of TFT were medium relative to non-directive control groups, and
not significantly different from non-TFT at follow-up. Effect size
estimates were of considerable heterogeneity and the number of
available comparisons was low.
The large and stable within-group effect sizes of psychological
treatment for PTSD in this meta-analysis are comparable with
previous results at both short-term and medium-term follow-up
(Ehring et al., 2014; Kline et al., 2018), yet uncontrolled compar-
isons must be interpreted cautiously. The between-group effect
size of psychological treatment compared with active control
groups is smaller than reported in a previous study with pooled
wait-list and active control groups as comparator at follow-up
(van Dis et al., 2020). However, the between-group effect size of
TFT relative to active control groups is consistent with the
previous finding. All active treatments included cognitive behav-
ioral therapy (CBT) with TFT most frequently (78%) studied
long-term, which is in line with previous evidence at medium-
term follow-up (e.g. Kline et al., 2018). The enduring treatment
effects of trauma-focused CBT after an average of 18 months con-
firm its recommendation as first-line therapy for PTSD (e.g. APA,
2017). One follow-up study was available on EMDR, yet the long-
term data were insufficient to be included for meta-analysis. This
finding highlights its current weaker empirical support as PTSD
treatment (APA, 2017), and lasting benefits beyond CBT out-
comes require future research. A few studies examined non-TFT
showing large and enduring benefits for PTSD, which mirrors
prior short-term findings regarding its empirical support and effi-
cacy (e.g. Ehring et al., 2014; Lenz et al., 2017; Powers et al., 2010).
Effect sizes of non-TFT were smaller compared with TFT at
follow-up as previously reported (Ehring et al., 2014), but the dif-
ference was statistically non-significant. Given the small number
of comparisons for non-TFT in particular, non-significant results
should be interpreted as the absence of statistical evidence rather
than as evidence of non-inferiority (Rief & Hofmann, 2018).
The within-group effect sizes of psychological treatments for
improved comorbid depressive symptoms were medium from
pretest to follow-up (or posttest), and smaller than previous find-
ings at short-term follow-up on treatments aiming to reduce
depression or PTSD (Morina, Malek, Nickerson, & Bryant,
2017). Between-group effect sizes at follow-up were also smaller
than in the previous study mainly comparing active treatments
to waitlist groups. Studies less frequently (73%) reported second-
ary depression outcomes at follow-up, and comparisons for
depressive symptoms were likely underpowered.
The included studies differed widely across sample-related and
treatment-related characteristics, and meta-analyses including the
present one are inherently associated with heterogeneous effect
sizes. In addition, dropout in active treatments was slightly higher
compared to previous rates from mixed populations (Kline et al.,
2018; Lewis, Roberts, Gibson, & Bisson, 2020), but lower than in
military samples alone (Goetter et al., 2015). TFT and non-TFT
types did not differ in dropout rates, which reflects some findings
(e.g. Imel, Laska, Jakupcak, & Simpson, 2013; Thompson et al.,
2018), and opposes others (Lewis et al., 2020).
Half of all studies (50%) were at high risk of bias in at least
two domains potentially increasing the risk of overestimated
treatment effects (e.g. Cuijpers, van Straten, Bohlmeijer,
Hollon, & Andersson, 2010b). Subgroup analysis indicated large






















A, alprazolam; AC, academic catch-up; B–CBT, brief cognitive behavioral therapy; BA + E, behavioral activation and exposure; BA + E TH, behavioral activation and exposure telehealth-based;
BDI–II, beck depression inventory–II; BDI, Beck depression inventory; C, d-cycloserine; CAPS, clinician-administered PTSD scale; CBT, cognitive behavioral therapy; CPT–M, cognitive
processing therapy modified; CPT, cognitive processing therapy; CR, cognitive restructuring; EG, educational group therapy; EMDR, eye movement desensitization and reprocessing; HADS,
hospital anxiety and depression scale – depression subscale; HAM–D, Hamilton depression scale; HDRS, Hamilton depression rating scale; ICBTcom, integrated cognitive behavioral treatment
for comorbidities; IOE, impact of events scale; IR, imagery rescripting therapy; MINI, mini international neuropsychiatric interview; n, sample size; n session, average number of sessions; NET,
narrative exposure therapy; NTF, non-trauma-focused treatment; PCL-C, PTSD checklist – civilian version; PCL-M, PTSD checklist – military version; PCLS, post-traumatic checklist scale; PCT,
present-centered therapy; PDSi, posttraumatic diagnostic scale – Interview-based; PE, prolonged exposure; Pla, placebo; PSS-I, PTSD symptom scale – Interview; PTSD, posttraumatic stress
disorder; SC, supportive counseling; Se, sertraline; SIT, stress inoculation training; SMT, self-management therapy; SS, seeking safety; TAU, treatment as usual; TF, trauma-focused treatment;
VR, virtual reality exposure therapy; WET, written exposure therapy; WL, wait-list.
aWe thank primary study authors for providing additional data and/or data subsets.
bTreatment condition was excluded from all meta-analyses.
cTreatment condition was excluded from follow-up meta-analysis.
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completer samples at follow-up. However, in ITT samples (but
not in completer samples) higher dropout was associated with lar-
ger effect sizes. This suggests that dropout is a critical source of
bias that ITT analyses may not fully resolve assuming data are
missing at random (White, Horton, Carpenter, & Pocock,
2011). In addition, treatment effects were significantly higher
for studies using interview-based outcome measures compared
to self-rated measures, challenging prior results from subgroup
analyses in PTSD (Kline et al., 2018; Lambert & Alhassoon,
2015). As suggested for depression outcomes earlier, self-rated
measures either underrated the improved symptoms, clinician-
rated interviews were more sensitive to change, or a combination
of both (Cuijpers, Li, Hofmann, & Andersson, 2010a).
The improved PTSD symptoms at follow-up in female and
civilian populations compared with male and military subgroups
replicate previous findings at short-term (Sloan et al., 2013; Watts
et al., 2013) and medium-term follow-up (Kline et al., 2018; Wade
et al., 2016). However, we noted that proportions of male partici-
pants were small in civilian populations but close to 100% in
military samples, and future studies with balanced samples need
to disentangle the effect of gender and population type.
Importantly, treatment effects for PTSD did not differ regarding
the length of follow-up duration, indicating that symptom
improvements persisted beyond 12 months after treatment. The
current number of studies with longer follow-up intervals is lim-
ited, and future evidence is required to confirm treatment gains
Table 2. Within-effect sizes (pretest – follow-up) and subgroup analyses for PTSD severity
k g 95% CI pa Q pb I2 pc
Condition <0.01
Active treatment 32 1.36 1.14–1.57 <0.001 194.34 <0.001 84.05
Active control 11 0.59 0.14–1.04 <0.05 132.38 <0.001 92.45
Passive control 1 –
Treatment typed 0.24
TFT 25 1.44 1.20–1.67 <0.001 132.08 <0.001 81.83
Non-TFT 7 1.08 0.52–1.63 <0.001 62.21 <0.001 90.36
Population <0.01
Military 10 0.93 0.69–1.18 <0.001 32.38 <0.001 72.21
Civilian 21 1.58 1.30–1.86 <0.001 102.89 <0.001 80.56
Proportion female
<50% 12 1.04 0.79–1.30 <0.001 47.23 <0.001 76.71 <0.001
⩾50% 18 1.62 1.34–1.90 <0.001 81.64 <0.001 79.18
PTSD measure <0.001
Interview-based 28 1.44 1.20–1.67 <0.001 158.82 <0.001 83.00
Self-rated 4 0.80 0.53–1.07 <0.001 5.16 0.16 41.91
Format 0.35
Group 4 1.00 0.18–1.82 <0.001 47.11 <0.001 93.63
Individual 28 1.41 1.18–1.63 <0.001 146.60 <0.001 81.58
Number of sessions 0.71
<10 sessions 14 1.31 1.05–1.57 <0.001 61.40 <0.001 78.82
⩾10 sessions 18 1.39 1.04–1.75 <0.001 132.88 <0.001 87.21
Type of analysis1 0.43
Intention-to-treat 18 1.42 1.15–1.70 <0.001 112.05 <0.001 84.83
Completer 14 1.25 0.94–1.57 <0.001 59.30 <0.001 78.08
Follow-up duration 0.05
12 months 26 1.26 1.03–1.49 <0.001 157.48 <0.001 84.13
>12 months 6 1.77 1.33–2.21 <0.001 14.84 <0.05 66.32
Note. Analyses based on 21 studies (20 for proportion female).
p-values less than 0.05 represent statistical significance. 95% CI = 95% confidence intervals, g = Hedges’ g, k = number of comparisons, PTSD = posttraumatic stress disorder.
1Additional subgroup analyses for PTSD indicated significantly larger treatment effects for intention-to-treat samples with higher compared to lower dropout rates (⩾20%; <20%, p < 0.01),
while treatment effects remained unaffected by losses to follow-up (<40%; ⩾40%, p = 0.61). In completer samples, attrition rates had no impact on treatment outcomes ( p = 0.56; p = 0.34).
ap-value of Hedges’ g.
bp-value of Q-statistics.
cp-value between groups.
dAnalyses include active treatments only.
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beyond 12 months following treatment. Subgroup analyses on
pre-specified moderators are exploratory and should be
interpreted with caution as additional study-level factors may
confound the results (Higgins & Green, 2011).
Strengths and limitations
This systematic review and meta-analysis on long-term benefits of
psychological treatment exceeds the number and variety of treat-
ment studies included in former meta-analyses for PTSD (Kline
et al., 2018; van Dis et al., 2020), and provides first evidence for
comorbid depressive symptoms in PTSD at long-term. In add-
ition, we performed a comprehensive literature search, adhered
closely to the PRISMA recommendations, and examined pre-
specified moderators of lasting treatment gains. However, there
are several limitations to be noted. First, publication bias could
not be tested due to small databases and considerable heterogen-
eity (Ioannidis & Trikalinos, 2007; Rothstein et al., 2005; Sterne
et al., 2006; Terrin et al., 2003). Second, several studies had
small sample sizes and included an unclear or high risk of bias.
We analyzed two bias domains with no impact on effect sizes,
but confidence in the results may remain limited. Third, the
number of comparisons at follow-up was low, and specific treat-
ment types beyond broad categories (i.e. TFT, non-TFT)
remained untested. Finally, the studies provided few and incon-
sistent data on additional treatment (e.g. medication) during psy-
chological treatment, and on whether participants received any
treatment during the follow-up phase. It remains unclear if ben-
efits can be ascribed to the initial psychological treatment alone.
Conclusion
The results of this meta-analysis on psychological treatment for
PTSD demonstrate large and sustained benefits after at least 12
months of follow-up. Active treatments were CBTs, and most
studies examined TFT. Effect sizes of TFT were large for improved
PTSD and medium for comorbid depressive symptoms from pre-
test to follow-up and superior to active control groups at follow-
up. Non-TFT showed small to large benefits for PTSD and
depressive symptoms from pretest to follow-up, respectively, but
the number of available studies was scarce. Future well-designed
studies are essential to determine the sustained gains from specific
CBT types and other psychological treatments, and to confirm
benefits beyond 12 months following initial treatment.
Table 3. Between-effect sizes at follow-up
k g 95% CI pa Q pb I2
PTSD severity
Treatment v. control 10 0.42 0.15–0.68 <0.001 29.76 <0.001 69.76
TFT v. control 8 0.51 0.15–0.86 <0.05 26.68 <0.001 73.76
TFT v. Non-TFT 3 0.35 −0.03 to 0.74 0.07 0.47 0.79 0.00
Non-TFT v. control 2 –
Comorbid depressive symptoms
Treatment v. control 7 0.15 −0.02 to 0.31 0.08 3.25 0.78 0.00
TFT v. control 6 0.14 −0.03 to 0.32 <0.05 85.27 <0.001 92.96
TFT v. Non-TFT 3 0.10 −0.38 to 0.58 0.68 2.73 0.25 26.83
Non-TFT v. control 1 –
Note. 95% CI = 95% confidence intervals, g = Hedges’ g, k = number of comparisons, PTSD = posttraumatic stress disorder, TFT = trauma-focused treatment.
ap-value of Hedges’ g.
bp-value of Q-statistics.
Table 4. Within-effect sizes (pretest, follow-up) and subgroup analyses for comorbid depressive symptoms
k g 95% CI pa Q pb I2 pc
Condition <0.05
Active treatment 24 0.73 0.55–0.71 <0.001 100.79 <0.001 77.18
Active control 7 0.34 0.11–0.58 <0.01 32.36 <0.001 81.46
Passive control 1 –
Treatment typed 0.06
TFT 20 0.78 0.58–0.99 <0.01 93.25 <0.001 79.63
Non-TFT 4 0.45 0.17–0.74 <0.01 4.54 0.21 33.91
Note. 95% CI = 95% confidence intervals, g = Hedges’ g, k = number of comparisons, PTSD = posttraumatic stress disorder.
ap-value of Hedges’ g.
bp-value of Q-statistics.
cp-value between groups.
dAnalyses include active treatments only.
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Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S003329172100163X.
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